Tessmer James F 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Mar 2, 2021
Insider Transaction Report
Form 4
Tessmer James F
VP, Finance & Acctg
Transactions
- Exercise/Conversion
Restricted Stock Units
2021-02-28−1,270→ 0 total→ Common Stock (1,270 underlying) - Exercise/Conversion
Common Stock
2021-02-28+1,270→ 66,397 total - Exercise/Conversion
Restricted Stock Units
2021-02-28−8,836→ 8,837 total→ Common Stock (8,836 underlying) - Exercise/Conversion
Common Stock
2021-02-28+4,213→ 70,610 total - Exercise/Conversion
Common Stock
2021-02-28+13,997→ 93,443 total - Tax Payment
Common Stock
2021-02-28$7.19/sh−10,765$77,400→ 82,678 total - Exercise/Conversion
Restricted Stock Units
2021-02-28−4,213→ 0 total→ Common Stock (4,213 underlying) - Exercise/Conversion
Common Stock
2021-02-28+8,836→ 79,446 total - Exercise/Conversion
Restricted Stock Units
2021-02-28−13,997→ 27,993 total→ Common Stock (13,997 underlying)
Footnotes (6)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
- [F4]Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter.
- [F5]Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter.
- [F6]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.